Transfection of the type II TGF-β receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype

Annals of Surgery

Volumn 227, Issue 6, 1998, Pages 781-789

  Mackay, Sally L D ^a,b   Auffenberg, Troy ^a   Tannahill, Cynthia L ^a   Ksontini, Riadh ^a   Josephs, Michael D ^a   Nowak, Monika ^a   Moldawer, Lyle L ^a   Copeland III, Edward M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

AFFINITY LABELING; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CULTURE; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SYNTHESIS; FRAMESHIFT MUTATION; GENETIC TRANSFECTION; GROWTH CURVE; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; SEQUENCE ANALYSIS; XENOGRAFT;

ANIMALS; AUTORADIOGRAPHY; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED NOD; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA-DIRECTED DNA POLYMERASE; TIME FACTORS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032461852     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199806000-00001     Document Type: Article

References (33)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
2. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994; 54:5059-5063.
3. Jeffreys AJ, Royle NJ, Wilson V, Wong Z. Spontaneous mutation rates to new length alleles at tandem-repetitive hypervariable loci in human DNA. Nature 1988; 332:278-281.
4. Moses HL, Tucker RF, Loef EB, et al. Type β transforming growth factor is a growth stimulator and growth inhibitor. In Feramisco J, Ozanne B, Stiles C, eds. Cancer cells. New York: Cold Spring Harbor Laboratory; 1985:65-75.
5. Roberts AB, Sporn MB. The transforming growth factor-betas. In Sporn M, Roberts AB, eds. Peptide growth factors and their receptors. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag; 1990:421-472.
6. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63:245-247.
7. Massague J, Boyd FT, Andres JL, Cheifetz S. Mediators of TGF-β action: TGF-β receptors and TGF-β binding proteoglycans. Ann NY Acad Sci 1990; 593:59-79.
8. Barnard JA. Beauchamp RD, Coffey RJ, Moses HL. Regulation of intestinal epithelial cell growth by transforming growth factor type B. Proc Natl Acad Sci USA 1989; 86:1578-1582.
9. Hoosein NM, McKnight MK, Levine AE, et al. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res 1989; 181:442-453.
10. Mulder KM, Ramey MK, Hoosein NM, et al. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line. Cancer Res 1988; 48:7120-7125.
11. Mulder KM, Zhong Q, Choi HG, Humphrey LE, Brattain MG. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells. Cancer Res 1990; 50:7581-7586.
12. MacKay SLD, Yaswen LR, Tamuzzer RW, et al. Colon cancer cells that are not growth inhibited by TGF-β lack functional type I and type II TGF-β receptors. Ann Surg 1995; 221:767-777.
13. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994; 370:341-347.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
15. Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995; 55:5545-5547.
16. Lin HY, Wang XF, Ng Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase [published erratum appears in Cell 1992 Sep 18; 70(6):following 1068]. Cell 1992; 68:775-785.
17. Schwab JH, Brown RR, Anderle SK, Schlievert PM. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol 1993; 150: 4151-4159.
18. Massague J. Identification of receptors for TGFB-β transforming growth factor. Methods Enzymol 1987; 146:174-195.
19. Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-4849.
20. Sun L, Wu G, Willson JK, et al. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994; 269:26449-26455.
21. Wang J, Sun L, Myeroff L. et al. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 1995; 270:22044-22049.
22. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1996; 7:93-102.
23. Coffey RJ Jr, Sipes NJ, Bascom CC, et al. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 1988; 48:1596-1602.
24. Boyd F, Massague J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem 1989; 264:2272-2278.
25. Pierce DF Jr, Gorska AE, Chytil A, et al. Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci USA 1995; 92:4254-4258.
26. Jhappan C, Gelser AG, Kordon EC, et al. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 1993; 12:1835-1845.
27. Sellheyer K, Bickenbach JR, Rothnagel JA, et al. Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 1993; 90:5237-5241.
28. Wang CY, Eshleman JR, Willson JKV, Markowitz S. Both transforming growth factor-β and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res 1995; 55:5101-5105.
29. Avery A, Paraskeva C, Hall P, et al. TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 1993; 68:137-139.
30. Coffey RJ Jr, Russell WE, Barnard JA. Pharmacokinetics of TGF beta with emphasis on effects in liver and gut. Ann NY Acad Sci 1990; 593:285-291.
31. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995; 55:5548-5550.
32. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268:1336-1338.
33. Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R. Growth factor production by human colon carcinoma cell lines. Cancer Res 1989; 49:2898-2904.